Scinai Immunotherapeutics Ltd. (SCNI) stock
SCNINasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$0.37−0.01 (-1.40%)
Close on Nov 18, 2026Market cap $1.27MP/E –Yield –
Scinai Immunotherapeutics price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Scinai Immunotherapeutics's price to sales ratio was 2.2× on Nov 11, 2026, against 23.7× a year earlier.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 2.2× | −14.2 |
| 2025 | Dec 31, 2025 | 16.4× | – |
See a number that looks wrong?